LCMS
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.
Pořadatel
Thermo Fisher Scientific
Thermo Fisher Scientific
Unikátní společnost, která se věnuje vědě a pomáhá našim zákazníkům zvyšovat produktivitu a získavat výsledky rychleji. Prostřednictvím našich předních značek - Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific a Unity Lab Services.
Tagy
LC/MS
LC/MS/MS
LC/Orbitrap
LC/HRMS
LinkedIn Logo

Toward early detection of congenital disease using Orbitrap Astral DIA MS/MS

ZÁZNAM | Proběhlo Čt, 26.2.2026
Zjistěte, jak systém Orbitrap Astral MS v režimu DIA umožňuje vysoce citlivou detekci variant IgG specifických pro parazity, což zlepšuje včasnou diagnostiku vrozené toxoplazmózy.
Přejít na webinář
Thermo Fisher Scientific: Omics innovations for the biopharmaceutical industry
Thermo Fisher Scientific: Omics innovations for the biopharmaceutical industry

This presentation describes a proof-of-concept mass spectrometry strategy to improve early diagnosis of congenital toxoplasmosis by distinguishing maternal and newborn immune responses. The work focuses on detecting IgG polymorphisms specific to Toxoplasma gondii using advanced LC-MS approaches, with particular emphasis on the Thermo Scientific Orbitrap Astral MS operated in DIA mode. Current diagnostic methods struggle to confirm fetal infection due to low parasite burden and the presence of maternal IgG in newborns. To address this, the team developed workflows to purify IgG subclasses, target parasite-specific antibodies, and identify subtle sequence variants differing by only one or two amino acids. While middle-down approaches lacked sensitivity for parasite-specific IgG, bottom-up DIA on the Thermo Scientific Orbitrap Astral MS enabled detection of low-abundance, discriminating peptides. Manual validation and fragment correlation were critical to eliminate false positives caused by high sequence homology. Overall, the study demonstrates Astral’s sensitivity and DIA capability for tackling extremely challenging, clinically relevant immunoproteomics problems.

Learning points:

  • Congenital toxoplasmosis diagnosis requires discrimination between maternal and newborn IgG
  • Orbitrap Astral MS DIA enables detection of ultra-low-abundance, polymorphic IgG peptides
  • Manual validation remains essential when analyzing highly homologous antibody sequences

Who should attend?

  • Researchers in clinical proteomics and infectious disease diagnostics
  • Scientists studying antibody polymorphisms, immunoproteomics, or neonatal immunity
  • Mass spectrometry experts interested in DIA strategies for extreme sensitivity challenges

This webinar is a recording from the Omics innovations for the biopharmaceutical industry seminar on December 11, 2025 in Strasbourg.

Cannot attend on February 26? Please register anyway to automatically receive access to the recording.

Presenter: Joëlle Vinh (Head of SMBP CNRS Biological MS and Proteomics Lab, ESPCI Paris)

Thermo Fisher Scientific
LinkedIn Logo
 

Mohlo by Vás zajímat

Oligonucleotide Analysis Using the Agilent InfinityLab Pro iQ and Altura Oligo HPH-C18 Column

Aplikace
| 2026 | Agilent Technologies
Instrumentace
LC/MS, LC/SQ, Spotřební materiál, LC kolony
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Aplikace
| 2026 | Thermo Fisher Scientific
Instrumentace
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Výrobce
Thermo Fisher Scientific
Zaměření
Metabolomika

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Aplikace
| 2026 | Agilent Technologies
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Agilent Technologies
Zaměření
Životní prostředí

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Aplikace
| 2026 | Waters
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Životní prostředí

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Aplikace
| 2026 | Waters
Instrumentace
LC/MS, LC/MS/MS, LC/HRMS, Charakterizace částic, LC/IT
Výrobce
Waters
Zaměření
Lipidomika
Další projekty
GCMS
ICPMS
Sledujte nás
FacebookX (Twitter)LinkedInYouTube
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.